Makita Corporation (MKTAY)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	8,661	8,848	7,594	6,700	8,799	11,649
Market Cap Growth	12.53%	16.51%	13.35%	-23.85%	-24.47%	39.26%
Enterprise Value	7,264	7,219	6,796	7,141	8,304	10,095
Last Close Price	32.30	33.20	28.34	24.84	32.12	43.00
PE Ratio	15.13	16.70	26.29	76.09	16.50	20.78
PS Ratio	1.68	1.76	1.55	1.17	1.45	2.12
PB Ratio	1.36	1.42	1.31	1.15	1.42	1.94
P/TBV Ratio	1.38	1.45	1.34	1.17	1.45	1.99
P/FCF Ratio	13.10	11.80	5.24	166.73	-	87.75
P/OCF Ratio	11.03	10.20	4.85	20.05	-	19.96
EV/Sales Ratio	1.44	1.44	1.39	1.24	1.36	1.84
EV/EBITDA Ratio	7.62	7.90	10.81	17.54	8.95	10.64
EV/EBIT Ratio	9.63	10.10	15.53	33.61	10.99	12.62
EV/FCF Ratio	10.99	9.63	4.69	177.71	-	76.04
Debt / Equity Ratio	0.03	0.01	0.02	0.24	0.11	0.00
Debt / EBITDA Ratio	0.16	0.07	0.21	3.44	0.71	0.02
Debt / FCF Ratio	0.24	0.09	0.09	34.89	-	0.18
Asset Turnover	0.69	0.70	0.69	0.73	0.81	0.82
Inventory Turnover	1.33	1.41	1.30	1.24	1.38	1.68
Quick Ratio	2.54	2.58	2.15	0.94	0.84	2.01
Current Ratio	5.49	5.44	4.77	2.58	3.06	4.44
Return on Equity (ROE)	-	8.76%	5.28%	1.51%	9.23%	10.12%
Return on Assets (ROA)	-	6.19%	3.84%	1.68%	6.30%	7.43%
Return on Capital (ROIC)	-	7.28%	4.45%	1.97%	7.65%	8.85%
Return on Capital Employed (ROCE)	11.70%	11.10%	7.30%	3.50%	11.70%	12.80%
Earnings Yield	6.61%	5.99%	3.80%	1.31%	6.06%	4.81%
FCF Yield	7.63%	8.47%	19.09%	0.60%	-15.31%	1.14%
Dividend Yield	2.37%	2.09%	1.33%	0.64%	1.85%	1.45%
Payout Ratio	35.83%	22.72%	12.99%	167.02%	28.93%	23.20%
Buyback Yield / Dilution	0.13%	0.17%	0.76%	-0.00%	-0.00%	-0.01%
Total Shareholder Return	2.50%	2.26%	2.09%	0.63%	1.84%	1.44%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.